Whole grain claims
This article was originally published in The Tan Sheet
FDA has denied a citizen petition requesting that the agency develop definitions for the claims "good source" and "excellent source" when used on labels for whole grain foods. The May 2004 filing by General Mills maintained that the claims needed a definition because they did not qualify as either nutrient content or health claims. FDA disagrees in a Nov. 8 letter to the petitioner, stating that they "clearly resemble nutrient content claims." The agency also says that questions about how to classify such label statements "have significant regulatory implications, not only for whole grains but also for other items in the diet that may be similarly situated." FDA also is "considering the development of guidance on what we consider the term 'whole grains' to include"...
You may also be interested in...
Most clinical trial sponsors view data disclosure as a mandate, maintaining regulatory compliance as a legal requirement. Study sponsors that realize the potential to repurpose this data, using a patient-first approach, turn transparency into a strategic advantage for engagement and recruitment efforts.
The Bio-Console 560 extracorporeal blood pumping console is being recalled over reports it could lose power during bypass surgery, which could lead to organ or neural dysfunction, blood clots, or even death.
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.